In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis
- PMID: 25239510
- DOI: 10.1016/j.ejps.2014.09.009
In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis
Abstract
In vitro blood-brain barrier (BBB) models from primary brain endothelial cells can closely resemble the in vivo BBB, offering valuable models to assay BBB functions and to screen potential central nervous system drugs. We have recently developed an in vitro BBB model using primary porcine brain endothelial cells. The model shows expression of tight junction proteins and high transendothelial electrical resistance, evidence for a restrictive paracellular pathway. Validation studies using small drug-like compounds demonstrated functional uptake and efflux transporters, showing the suitability of the model to assay drug permeability. However, one limitation of in vitro model permeability measurement is the presence of the aqueous boundary layer (ABL) resulting from inefficient stirring during the permeability assay. The ABL can be a rate-limiting step in permeation, particularly for lipophilic compounds, causing underestimation of the permeability. If the ABL effect is ignored, the permeability measured in vitro will not reflect the permeability in vivo. To address the issue, we explored the combination of in vitro permeability measurement using our porcine model with the pKa(FLUX) method in pCEL-X software to correct for the ABL effect and allow a detailed analysis of in vitro (transendothelial) permeability data, Papp. Published Papp using porcine models generated by our group and other groups are also analyzed. From the Papp, intrinsic transcellular permeability (P0) is derived by simultaneous refinement using a weighted nonlinear regression, taking into account permeability through the ABL, paracellular permeability and filter restrictions on permeation. The in vitro P0 derived for 22 compounds (35 measurements) showed good correlation with P0 derived from in situ brain perfusion data (r(2)=0.61). The analysis also gave evidence for carrier-mediated uptake of naloxone, propranolol and vinblastine. The combination of the in vitro porcine model and the software analysis provides a useful tool to better predict BBB permeability in vivo and gain better mechanistic information about BBB permeation.
Keywords: Acetylsalicylic acid (PubChem CID: 2244); Aqueous boundary layer; Blood–brain barrier; Caffeine (PubChem CID: 64136); Colchicine (PubChem CID: 6167); Dexamethasone (PubChem CID: 5743); Diazepam (PubChem CID: 3016); In vitro model; Naloxone (PubChem CID: 5284596); Permeability; Phenytoin (PubChem CID: 1775); Propranolol (PubChem CID: 62882); Vinblastine (PubChem CID: 241902); l-Leucine (PubChem CID: 6106); pCEL-X software.
Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability?Eur J Pharm Sci. 2011 Jun 14;43(3):109-24. doi: 10.1016/j.ejps.2011.04.001. Epub 2011 Apr 14. Eur J Pharm Sci. 2011. PMID: 21514381
-
Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.Drug Metab Dispos. 2006 Nov;34(11):1935-43. doi: 10.1124/dmd.105.006437. Epub 2006 Aug 8. Drug Metab Dispos. 2006. PMID: 16896068
-
Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.Mol Pharm. 2019 May 6;16(5):2069-2082. doi: 10.1021/acs.molpharmaceut.9b00042. Epub 2019 Apr 4. Mol Pharm. 2019. PMID: 30916978
-
Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.Eur J Pharm Biopharm. 2014 Aug;87(3):409-32. doi: 10.1016/j.ejpb.2014.03.012. Epub 2014 Mar 28. Eur J Pharm Biopharm. 2014. PMID: 24686194 Review.
-
In vitro models of the blood-brain barrier for the study of drug delivery to the brain.Mol Pharm. 2014 Jul 7;11(7):1949-63. doi: 10.1021/mp500046f. Epub 2014 Apr 18. Mol Pharm. 2014. PMID: 24641309 Review.
Cited by
-
In Vitro Models of the Human Blood-Brain Barrier Utilising Human Induced Pluripotent Stem Cells: Opportunities and Challenges.Methods Mol Biol. 2022;2492:53-72. doi: 10.1007/978-1-0716-2289-6_3. Methods Mol Biol. 2022. PMID: 35733038
-
In vitro models of molecular and nano-particle transport across the blood-brain barrier.Biomicrofluidics. 2018 May 31;12(4):042213. doi: 10.1063/1.5027118. eCollection 2018 Jul. Biomicrofluidics. 2018. PMID: 29887937 Free PMC article.
-
An experimentally validated approach to calculate the blood-brain barrier permeability of small molecules.Sci Rep. 2019 Apr 16;9(1):6117. doi: 10.1038/s41598-019-42272-0. Sci Rep. 2019. PMID: 30992465 Free PMC article.
-
The endo-lysosomal system of bEnd.3 and hCMEC/D3 brain endothelial cells.Fluids Barriers CNS. 2019 May 30;16(1):14. doi: 10.1186/s12987-019-0134-9. Fluids Barriers CNS. 2019. PMID: 31142333 Free PMC article.
-
IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening.Pharmaceutics. 2019 Nov 8;11(11):587. doi: 10.3390/pharmaceutics11110587. Pharmaceutics. 2019. PMID: 31717321 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous